These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
315 related articles for article (PubMed ID: 27487958)
21. Protocol for the detection of Mycoplasma genitalium by PCR from clinical specimens and subsequent detection of macrolide resistance-mediating mutations in region V of the 23S rRNA gene. Jensen JS Methods Mol Biol; 2012; 903():129-39. PubMed ID: 22782815 [TBL] [Abstract][Full Text] [Related]
22. Failure of moxifloxacin treatment in Mycoplasma genitalium infections due to macrolide and fluoroquinolone resistance. Couldwell DL; Tagg KA; Jeoffreys NJ; Gilbert GL Int J STD AIDS; 2013 Oct; 24(10):822-8. PubMed ID: 24052013 [TBL] [Abstract][Full Text] [Related]
23. High Macrolide Resistance in Mycoplasma genitalium Strains Causing Infection in Auckland, New Zealand. Basu I; Roberts SA; Bower JE; Henderson G; Reid M J Clin Microbiol; 2017 Jul; 55(7):2280-2282. PubMed ID: 28468853 [No Abstract] [Full Text] [Related]
24. Macrolide resistance in Mycoplasma genitalium from female sex workers in Belgium. Coorevits L; Traen A; Bingé L; Descheemaeker P; Boelens J; Reynders M; Padalko E J Glob Antimicrob Resist; 2018 Mar; 12():149-152. PubMed ID: 28988903 [TBL] [Abstract][Full Text] [Related]
26. Low prevalence of macrolide resistance in Ngobese B; Swe Swe-Han K; Tinarwo P; Abbai NS Int J STD AIDS; 2022 Dec; 33(14):1174-1182. PubMed ID: 36218027 [TBL] [Abstract][Full Text] [Related]
27. Detection of macrolide and fluoroquinolone resistance-associated 23S rRNA and parC mutations in Mycoplasma genitalium by nested real-time PCR. He W; Yuan Y; Liang J; Fan X; Li L; Pan X Front Cell Infect Microbiol; 2023; 13():1271392. PubMed ID: 37928183 [TBL] [Abstract][Full Text] [Related]
28. Increased macrolide resistance of Mycoplasma pneumoniae in France directly detected in clinical specimens by real-time PCR and melting curve analysis. Peuchant O; Ménard A; Renaudin H; Morozumi M; Ubukata K; Bébéar CM; Pereyre S J Antimicrob Chemother; 2009 Jul; 64(1):52-8. PubMed ID: 19429926 [TBL] [Abstract][Full Text] [Related]
29. Prevalence of Mycoplasma genitalium and mutations associated with macrolide and fluoroquinolone resistance in Finland. Hokynar K; Hiltunen-Back E; Mannonen L; Puolakkainen M Int J STD AIDS; 2018 Aug; 29(9):904-907. PubMed ID: 29631509 [TBL] [Abstract][Full Text] [Related]
30. Evaluation of the Pitt R; Cole MJ; Fifer H; Woodford N Sex Transm Infect; 2018 Dec; 94(8):565-567. PubMed ID: 29101246 [TBL] [Abstract][Full Text] [Related]
31. Guided antibiotic therapy for Mycoplasma genitalium infections: Analysis of mutations associated with resistance to macrolides and fluoroquinolones. Piñeiro L; Idigoras P; de la Caba I; López-Olaizola M; Cilla G Enferm Infecc Microbiol Clin (Engl Ed); 2019; 37(6):394-397. PubMed ID: 30396750 [TBL] [Abstract][Full Text] [Related]
32. Mycoplasma genitalium Macrolide and Fluoroquinolone Resistance Detection and Clinical Implications in a Selected Cohort in New Zealand. Anderson T; Coughlan E; Werno A J Clin Microbiol; 2017 Nov; 55(11):3242-3248. PubMed ID: 28878004 [No Abstract] [Full Text] [Related]
33. Macrolide resistance-associated 23S rRNA mutation in Mycoplasma genitalium, Japan. Shimada Y; Deguchi T; Nakane K; Yasuda M; Yokoi S; Ito S; Nakano M; Ito S; Ishiko H Emerg Infect Dis; 2011 Jun; 17(6):1148-50. PubMed ID: 21749801 [No Abstract] [Full Text] [Related]
34. Selection of Mycoplasma genitalium strains harbouring macrolide resistance-associated 23S rRNA mutations by treatment with a single 1 g dose of azithromycin. Ito S; Shimada Y; Yamaguchi Y; Yasuda M; Yokoi S; Ito S; Nakano M; Ishiko H; Deguchi T Sex Transm Infect; 2011 Aug; 87(5):412-4. PubMed ID: 21653933 [TBL] [Abstract][Full Text] [Related]
35. Mycoplasma genitalium prevalence and macrolide resistance-associated mutations and coinfection with Chlamydia trachomatis in Southern Jutland, Denmark. Desdorf R; Andersen NM; Chen M APMIS; 2021 Dec; 129(12):706-710. PubMed ID: 34580906 [TBL] [Abstract][Full Text] [Related]
36. Time to eradication of Mycoplasma genitalium after antibiotic treatment in men and women. Falk L; Enger M; Jensen JS J Antimicrob Chemother; 2015 Nov; 70(11):3134-40. PubMed ID: 26283670 [TBL] [Abstract][Full Text] [Related]
37. Prevalence of mutations associated with resistance to macrolides and fluoroquinolones in Mycoplasma genitalium: a systematic review and meta-analysis. Machalek DA; Tao Y; Shilling H; Jensen JS; Unemo M; Murray G; Chow EPF; Low N; Garland SM; Vodstrcil LA; Fairley CK; Hocking JS; Zhang L; Bradshaw CS Lancet Infect Dis; 2020 Nov; 20(11):1302-1314. PubMed ID: 32622378 [TBL] [Abstract][Full Text] [Related]
38. Mutations in ParC and GyrA of moxifloxacin-resistant and susceptible Mycoplasma genitalium strains. Hamasuna R; Le PT; Kutsuna S; Furubayashi K; Matsumoto M; Ohmagari N; Fujimoto N; Matsumoto T; Jensen JS PLoS One; 2018; 13(6):e0198355. PubMed ID: 29883482 [TBL] [Abstract][Full Text] [Related]
39. Drug resistance-associated mutations in Mycoplasma genitalium in female sex workers, Japan. Deguchi T; Yasuda M; Horie K; Seike K; Kikuchi M; Mizutani K; Tsuchiya T; Yokoi S; Nakano M; Hoshina S Emerg Infect Dis; 2015 Jun; 21(6):1062-4. PubMed ID: 25988775 [TBL] [Abstract][Full Text] [Related]
40. Macrolide and fluoroquinolone resistance in Mycoplasma genitalium in two Swedish counties, 2011-2015. Hadad R; Golparian D; Lagos AC; Ljungberg J; Nilsson P; Jensen JS; Fredlund H; Unemo M APMIS; 2018 Feb; 126(2):123-127. PubMed ID: 29235145 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]